Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Cacciamani

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Neurology|April 16, 2024
Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO CohortLeslie Grasset, Vincent Bouteloup, Federica Cacciamani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentFederica Cacciamani, Graziella Mangin Laignel, Audrey Gabelle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsFederica Cacciamani, Graziella Mangin Laignel, Audrey Gabelle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsFederica Cacciamani, Graziella Mangin Laignel, Audrey Gabelle, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2019
Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's diseaseSarah-Christine Villeneuve, Marion Houot, Federica Cacciamani, et al.
Neuroimage. Clinical|December 11, 2025
Multimodal neural correlates of cognitive awareness in aging and Alzheimer's diseaseFederica Cacciamani, Marion Houot, Sophie Tezenas du Montcel, et al.
Experimental Gerontology|February 1, 2022
Subtle postoperative cognitive disorder in preclinical Alzheimer's diseasePauline Glasman, Marion Houot, Raffaela Migliaccio, et al.
Frontiers in Aging Neuroscience|March 21, 2024
Anosognosia is associated with increased prevalence and faster development of neuropsychiatric symptoms in mild cognitive impairmentSharon Wang, Kayden Mimmack, Federica Cacciamani, et al.
Journal of Alzheimer'S Disease : JAD|July 4, 2017
Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's DiseaseFederica Cacciamani, Caroline Tandetnik, Geoffroy Gagliardi, et al.
Frontiers in Aging Neuroscience|August 20, 2021
Awareness of Cognitive Decline in Patients With Alzheimer's Disease: A Systematic Review and Meta-AnalysisFederica Cacciamani, Marion Houot, Geoffroy Gagliardi, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Neurology|April 16, 2024
Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO CohortLeslie Grasset, Vincent Bouteloup, Federica Cacciamani, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentFederica Cacciamani, Graziella Mangin Laignel, Audrey Gabelle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsFederica Cacciamani, Graziella Mangin Laignel, Audrey Gabelle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Clinical ManifestationsFederica Cacciamani, Graziella Mangin Laignel, Audrey Gabelle, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2019
Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's diseaseSarah-Christine Villeneuve, Marion Houot, Federica Cacciamani, et al.
Neuroimage. Clinical|December 11, 2025
Multimodal neural correlates of cognitive awareness in aging and Alzheimer's diseaseFederica Cacciamani, Marion Houot, Sophie Tezenas du Montcel, et al.
Experimental Gerontology|February 1, 2022
Subtle postoperative cognitive disorder in preclinical Alzheimer's diseasePauline Glasman, Marion Houot, Raffaela Migliaccio, et al.
Frontiers in Aging Neuroscience|March 21, 2024
Anosognosia is associated with increased prevalence and faster development of neuropsychiatric symptoms in mild cognitive impairmentSharon Wang, Kayden Mimmack, Federica Cacciamani, et al.
Journal of Alzheimer'S Disease : JAD|July 4, 2017
Low Cognitive Awareness, but Not Complaint, is a Good Marker of Preclinical Alzheimer's DiseaseFederica Cacciamani, Caroline Tandetnik, Geoffroy Gagliardi, et al.
Frontiers in Aging Neuroscience|August 20, 2021
Awareness of Cognitive Decline in Patients With Alzheimer's Disease: A Systematic Review and Meta-AnalysisFederica Cacciamani, Marion Houot, Geoffroy Gagliardi, et al.
Pageof 3